11C-JMJ-129
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 11C-JMJ-129, covering 2026-03-03 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers [Phase 1]